Actively Recruiting
Randomized Study of PSTC100 Safety, Tolerability, and Pharmacokinetics in Healthy Adults Using Single and Multiple Ascending Doses
Led by Prospect Therapeutics (Nanjing) Limited · Updated on 2026-09-04
70
Participants Needed
1
Research Sites
12 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a Phase I clinical trial to study PSTC100 in healthy adult volunteers aged 18 to 55 years. The goal is to assess the safety, tolerability, and how the drug behaves in the body, including its pharmacokinetic and pharmacodynamic properties. This randomized, double-blind, placebo-controlled study uses a dose-escalation approach to carefully evaluate varying doses under controlled conditions. The study is divided into two parts. Part 1 tests single ascending doses ranging from 25 mg to 400 mg across six dose cohorts, with subjects receiving a one-time dose of PSTC100 or placebo while fasting. Part 2 evaluates multiple ascending doses of 100 mg to 300 mg given once daily for seven consecutive days in three dose cohorts. Each cohort includes both investigational drug and placebo groups to compare responses. Participants will undergo screening to confirm eligibility, then receive study drug or placebo according to their assigned dose cohort. Researchers will monitor participants closely through physical exams, vital signs, ECGs, and laboratory tests, collecting blood and urine samples at specified times to measure drug levels and metabolic effects. The primary measurements include drug concentration over time, peak levels, and elimination characteristics. Safety and tolerability will be assessed throughout the study, which lasts from initial dosing through follow-up visits. Total participation spans screening and dosing periods with detailed monitoring.
CONDITIONS
Brief Title
PSTC100 Study in Healthy Adult Subjects
Research Team
V
Victor Wong, Doctor
A
Alice Hu
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here